Literature DB >> 26317639

Mismatching between circulating strains and vaccine strains of influenza: Effect on Hajj pilgrims from both hemispheres.

Mohammad Alfelali1,2, Gulam Khandaker1,3,4, Robert Booy1,4, Harunor Rashid1,4.   

Abstract

The trivalent seasonal influenza vaccine is expected to provide optimum protection if the vaccine strains match the circulating strains. The effect of worldwide mismatch between the vaccine strains and extant strains on travelers attending Hajj pilgrimage is not known. Annually 2-3 million Muslims coming from north and south hemispheres congregate at Hajj in Mecca, Saudi Arabia, where intense congestion amplifies the risk of respiratory infection up to eight fold. In order to estimate, to what extent mismatching increases the risk of vaccine failure in Hajj pilgrims, we have examined the global data on influenza epidemiology since 2003, in light of the available data from Hajj. These data demonstrate that globally mismatching between circulating and vaccine strains has occurred frequently over the last 12 years, and the mismatch seems to have affected the Hajj pilgrims, however, influenza virus characteristics were studied only in a limited number of Hajj seasons. When the vaccines are different, dual vaccination of travelers by vaccines for southern and northern hemispheres should be considered for Hajj pilgrims whenever logistically feasible. Consideration should also be given to the use of vaccines with broader coverage, i.e., quadrivalent, or higher immunogenicity. Continuous surveillance of influenza at Hajj is important.

Entities:  

Keywords:  Hajj; influenza; mass gathering; mismatch; strains; travel; vaccine

Mesh:

Substances:

Year:  2016        PMID: 26317639      PMCID: PMC4964745          DOI: 10.1080/21645515.2015.1085144

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  41 in total

1.  Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars province, Iran.

Authors:  Afagh Moattari; Amir Emami; Mohsen Moghadami; Behnam Honarvar
Journal:  Influenza Other Respir Viruses       Date:  2012-05-21       Impact factor: 4.380

Review 2.  Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults.

Authors:  Steven Black
Journal:  Vaccine       Date:  2015-06-08       Impact factor: 3.641

Review 3.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Authors:  Michael T Osterholm; Nicholas S Kelley; Alfred Sommer; Edward A Belongia
Journal:  Lancet Infect Dis       Date:  2011-10-25       Impact factor: 25.071

4.  Pilot Randomised Controlled Trial to Test Effectiveness of Facemasks in Preventing Influenza-like Illness Transmission among Australian Hajj Pilgrims in 2011.

Authors:  Osamah Barasheed; Nedal Almasri; Al-Mamoon Badahdah; Leon Heron; Janette Taylor; Kenneth McPhee; Iman Ridda; Elizabeth Haworth; Dominic E Dwyer; Harunor Rashid; Robert Booy
Journal:  Infect Disord Drug Targets       Date:  2014

Review 5.  Oseltamivir for control of influenza at mass gatherings.

Authors:  Mohamed Tashani; Harunor Rashid; Iman Ridda; Leon Heron; Ziad A Memish; Elizabeth Haworth; Robert Booy
Journal:  Infect Disord Drug Targets       Date:  2013-02

6.  Influenza among U.K. pilgrims to hajj, 2003.

Authors:  Haitham El Bashir; Elizabeth Haworth; Maria Zambon; Shuja Shafi; Jane Zuckerman; Robert Booy
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

7.  Influenza A and B Viruses but Not MERS-CoV in Hajj Pilgrims, Austria, 2014.

Authors:  Judith H Aberle; Theresia Popow-Kraupp; Peter Kreidl; Hermann Laferl; Franz X Heinz; Stephan W Aberle
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

8.  Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage.

Authors:  Samir Benkouiten; Rémi Charrel; Khadidja Belhouchat; Tassadit Drali; Nicolas Salez; Antoine Nougairede; Christine Zandotti; Ziad A Memish; Malak al Masri; Catherine Gaillard; Philippe Parola; Philippe Brouqui; Philippe Gautret
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

9.  Influenza vaccine for Hajj and Umrah pilgrims.

Authors:  Remi N Charrel; Antoine Nougairede; Philippe Brouqui; Didier Raoult; Philippe Gautret
Journal:  Lancet Infect Dis       Date:  2015-03       Impact factor: 25.071

10.  Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims.

Authors:  H Rashid; S Shafi; E Haworth; H El Bashir; Z A Memish; M Sudhanva; M Smith; H Auburn; R Booy
Journal:  Clin Microbiol Infect       Date:  2008-03-26       Impact factor: 8.067

View more
  11 in total

1.  International mass gatherings and travel-associated illness: A GeoSentinel cross-sectional, observational study.

Authors:  Philippe Gautret; Kristina M Angelo; Hilmir Asgeirsson; Alexandre Duvignaud; Perry J J van Genderen; Emmanuel Bottieau; Lin H Chen; Salim Parker; Bradley A Connor; Elizabeth D Barnett; Michael Libman; Davidson H Hamer
Journal:  Travel Med Infect Dis       Date:  2019-11-09       Impact factor: 6.211

2.  Epidemic situation of the complex seasonality of imported influenza A and B virus transmission in Guangxi ports of China

Authors:  Xiangjuan Li; Zhongping Liang; Jie Gan; Lingmin Lu
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

3.  Influenza immunization and surveillance in Saudi Arabia.

Authors:  Anwar M Hashem
Journal:  Ann Thorac Med       Date:  2016 Apr-Jun       Impact factor: 2.219

4.  Clinical respiratory infections and pneumonia during the Hajj pilgrimage: A systematic review.

Authors:  Samir Benkouiten; Jaffar A Al-Tawfiq; Ziad A Memish; Ali Albarrak; Philippe Gautret
Journal:  Travel Med Infect Dis       Date:  2018-12-04       Impact factor: 6.211

5.  Association of Consecutive Influenza Vaccinations and Pneumonia: A Population-Based Case-Control Study.

Authors:  Liang-Tsai Yeh; Chi-Ho Chan; Shun-Fa Yang; Han-Wei Yeh; Ying-Tung Yeh; Yu-Hsun Wang; Ming-Chih Chou; Chao-Bin Yeh; Ying-Hock Teng
Journal:  Int J Environ Res Public Health       Date:  2019-03-26       Impact factor: 3.390

6.  Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.

Authors:  Keita Fukao; Yoshinori Ando; Takeshi Noshi; Mitsutaka Kitano; Takahiro Noda; Makoto Kawai; Ryu Yoshida; Akihiko Sato; Takao Shishido; Akira Naito
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

7.  MERS-CoV, influenza and other respiratory viruses among symptomatic pilgrims during 2014 Hajj season.

Authors:  Anwar M Hashem; Tagreed L Al-Subhi; Nassrin A Badroon; Ahmed M Hassan; Leena Hussein M Bajrai; Talib M Banassir; Khalid M Alquthami; Esam I Azhar
Journal:  J Med Virol       Date:  2019-02-20       Impact factor: 2.327

Review 8.  Uptake and effectiveness of facemask against respiratory infections at mass gatherings: a systematic review.

Authors:  Osamah Barasheed; Mohammad Alfelali; Sami Mushta; Hamid Bokhary; Jassir Alshehri; Ammar A Attar; Robert Booy; Harunor Rashid
Journal:  Int J Infect Dis       Date:  2016-03-29       Impact factor: 3.623

Review 9.  Expected immunizations and health protection for Hajj and Umrah 2018 -An overview.

Authors:  Jaffar A Al-Tawfiq; Philippe Gautret; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2017-10-14       Impact factor: 6.211

Review 10.  Improving immunological insights into the ferret model of human viral infectious disease.

Authors:  Julius Wong; Daniel Layton; Adam K Wheatley; Stephen J Kent
Journal:  Influenza Other Respir Viruses       Date:  2019-10-03       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.